Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
UAB professor receives award for malaria prevention study in pregnant women in Cameroon

UAB professor receives award for malaria prevention study in pregnant women in Cameroon

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

California’s deadly STD epidemic sets record

California’s deadly STD epidemic sets record

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Faster detection, treatment of anemia made possible with production of new portable diagnostic device

Faster detection, treatment of anemia made possible with production of new portable diagnostic device

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

EKF receives FDA clearance and CLIA waiver for reagent-free hemoglobin analyzer

EKF receives FDA clearance and CLIA waiver for reagent-free hemoglobin analyzer

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

Study shows effectiveness of novel risk tool to predict readmission rates after TAVR

Study shows effectiveness of novel risk tool to predict readmission rates after TAVR

Study finds myeloma precursor disease in 9/11 firefighters

Study finds myeloma precursor disease in 9/11 firefighters

Scientists use CRISPR tool to make multiple edits to DNA samples 'in vitro'

Scientists use CRISPR tool to make multiple edits to DNA samples 'in vitro'

Low-cost deworming drug improves female farmers' physical fitness

Low-cost deworming drug improves female farmers' physical fitness

Researcher explores how children develop immunity to malaria as they grow older

Researcher explores how children develop immunity to malaria as they grow older

New discovery may offer insight into treating sickle cell anemia and other blood disorders

New discovery may offer insight into treating sickle cell anemia and other blood disorders

Insights into blood cell formation may help break new ground in treatment of anemia

Insights into blood cell formation may help break new ground in treatment of anemia

Human genome is like a time machine, says researcher

Human genome is like a time machine, says researcher

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL